DR. KEVIN R STONE, MD
Medical Practice at Buchanan St, San Francisco, CA
License number
California A39288
Category
Medical Practice
Type
Specialist
Address
Address
3727 Buchanan St, San Francisco, CA 94123
Phone
(415) 563-3110
(415) 563-3301 (Fax)
(415) 563-3301 (Fax)
Organization information
See more information about KEVIN R STONE at bizstanding.comKevin R Stone
3727 Buchanan St STE 300, San Francisco, CA 94123
Phone:
(415) 563-3110 (Phone), (415) 563-3301 (Fax)
Orthopedic Clinical Specialists:
Damon Somers (Senior Operations Consultant),Kelly Starrett (Founder),Emily Miller (Consultant),...
SIC6:
801105 - Physicians & Surgeons-Emergency Service
Company size:
7
Professional information
Contract Specialist At Dept Of Veterans Affairs
Position:
Contract Specialist at Dept of Veterans Affairs
Location:
San Francisco Bay Area
Industry:
Government Administration
Work:
Dept of Veterans Affairs
- Palo Alto, CA since Jun 2012
-
Contract Specialist
Department of Veterans Affairs
- Dept. of Veterans Affairs Palo Alto, CA Nov 2005 - Jun 2012
-
SUPPLY TECHNICIAN
Flur Daniels
- San Jose, CA Apr 1998 - May 1999
-
Contract Administrator
Education:
San Jose State University 1991 - 1993
BA, ECONOMICS
BA, ECONOMICS
Postdoc At Lbnl
Position:
Post Doctoral Researcher at Lawrence Berkeley National Laboratory
Location:
San Francisco Bay Area
Industry:
Research
Work:
Lawrence Berkeley National Laboratory
since Jan 2010
-
Post Doctoral Researcher
Stony Brook University
Aug 2005 - Dec 2009
-
Graduate Research Assistant
Lawrence Berkeley National Labs
Aug 1999 - Jun 2000
-
Research Assistant
Education:
State University of New York at Stony Brook 2004 - 2009
PhD, Physics University of California, Berkeley 2000 - 2004
BA, Physics
PhD, Physics University of California, Berkeley 2000 - 2004
BA, Physics
Skills:
Spectroscopy, Data Analysis, Powder X-ray Diffraction, X-ray crystallography, Python, Characterization, Experimentation, Nanotechnology, Labview, Mathematica, LaTeX, Physics
Method For Making A Prosthetic Intervertebral Disc
US Patent:
5258043, Nov 2, 1993
Filed:
Dec 26, 1991
Appl. No.:
7/813984
Inventors:
Kevin R. Stone - San Francisco CA
Assignee:
ReGen Corporation - San Francisco CA
International Classification:
A61F 202, A61F 244
US Classification:
623 66
Abstract:
A prosthetic intervertebral disc is disclosed which can be implanted in the human skeleton, and which can act as a scaffold for regrowth of intervertebral disc material. The disc includes a dry, porous, volume matrix of biocompatible and bioresorbable fibers which may be interspersed with glyscosaminoglycan molecules. The matrix is adapted to have in vivo an outer surface contour substantially the same as that of a natural intervertebral disc, whereby the matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of intervertebral fibrochondrocytes. Cross-links may be provided by a portion of the GAG molecules.
Anterior Cruciate Ligament Heterograft
US Patent:
6063120, May 16, 2000
Filed:
Feb 12, 1998
Appl. No.:
9/022658
Inventors:
Kevin R. Stone - San Francisco CA
International Classification:
A61F 208
US Classification:
623 13
Abstract:
The invention provides an article of manufacture comprising a substantially non-immunogenic ligament or tendon heterografts for implantation into humans. The invention further provides a method for preparing an ligament heterograft by removing at least a portion of an ligament from a non-human animal to provide a heterograft; washing the heterograft in saline and alcohol; subjecting the heterograft to at least one treatment selected from the group consisting of exposure to ultraviolet radiation, immersion in alcohol, ozonation, freeze/thaw cycling, and optionally to chemical crosslinking. In accordance with the invention the heterograft has substantially the same mechanical properties as the native xenogeneic ligament.
Prosthetic Intervertebral Disc
US Patent:
5108438, Apr 28, 1992
Filed:
May 7, 1990
Appl. No.:
7/520027
Inventors:
Kevin R. Stone - San Francisco CA
Assignee:
ReGen Corporation - San Francisco CA
International Classification:
A61F 244
US Classification:
623 17
Abstract:
A prosthetic intervertebral disc is disclosed which can be implanted in the human skeleton, and which can act as a scaffold for regrowth of intervertebral disc material. The disc includes a dry, porous, volume matrix of biocompatible and bioresorbable fibers which may be interspersed with glyscosaminoglycan molecules. The matrix is adapted to have in vivo an outer surface contour substantially the same as that of a natural intervertebral disc, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of intervertebral fibrochondrocytes. Cross-links may be provided by a portion of the GAG molecules.
Thin Shell Graft For Cartilage Resurfacing
US Patent:
2012020, Aug 16, 2012
Filed:
Feb 15, 2012
Appl. No.:
13/397540
Inventors:
KEVIN R. STONE - San Francisco CA, US
THOMAS J. TUREK - Pacifica CA, US
THOMAS J. TUREK - Pacifica CA, US
International Classification:
A61F 2/08, A61P 19/00, A61K 35/32
US Classification:
424 937, 623 1412
Abstract:
An articular cartilage shell graft is designed to treat the arthritic population for which current biologic treatments are insufficient and as a biological-stage repair for intervention before prosthetic knee arthroplasty.
Prosthetic Meniscus
US Patent:
5007934, Apr 16, 1991
Filed:
Mar 2, 1989
Appl. No.:
7/317951
Inventors:
Kevin R. Stone - San Francisco CA
Assignee:
ReGen Corporation - San Francisco CA
International Classification:
A61F 238
US Classification:
623 20
Abstract:
A prosthetic, resorbable meniscus and method of its fabrication are disclosed. The prosthetic meniscus can be implanted in a human knee where it can act as a scaffold for regrowth of native meniscal tissues. The meniscus comprises a dry, porous, matrix of biocompatible and bioresorbable fibers, at least a portion of which may be crosslinked. The fibers include natural polymers or analogs or mixtures thereof. The matrix is adapted to have in vivo an outer surface contour substantially the same as that of a natural meniscus. The matrix has pore size in the approximate range of greater than 50 microns to less than about 500 microns. With this configuration, the matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of meniscal fibrochondrocytes.
Prosthetic Meniscus
US Patent:
4880429, Nov 14, 1989
Filed:
Jul 20, 1987
Appl. No.:
7/075352
Inventors:
Kevin R. Stone - San Francisco CA
International Classification:
A61F 230
US Classification:
623 18
Abstract:
A prosthetic meniscus is disclosed which can be implanted in a humanoid knee, and which can act as a scaffold for regrowth of native meniscal tissues. The meniscus comprises a three dimensional array of collagen fibers interspersed with glycosaminoglycan molecules. The collagen fibers are present at a concentration of about 65 to 98 percent by dry weight, and the glycosaminoglycan molecules are present at a concentration of about 1 to 25 percent by dry weight. Crosslinks are provided by at least a portion of the glycosaminoglycan molecules, and may consist of at least one of the group comprising chondroitan 4-sulfate, chondroitan 6-sulfate, keritan sulfate, dermatan sulfate, heparin sulfate, and hyaluronic acid.
Prosthetic Meniscus
US Patent:
5116374, May 26, 1992
Filed:
Sep 13, 1990
Appl. No.:
7/582516
Inventors:
Kevin R. Stone - San Francisco CA
Assignee:
ReGen Corporation - San Francisco CA
International Classification:
A61F 220
US Classification:
623 16
Abstract:
A prosthetic, resorbable meniscus and method of its fabrication are disclosed. The prosthetic meniscus can be implanted in a human knee where it can act as a scaffold for regrowth of native meniscal tissues. The meniscus comprises a dry, porous, matrix of biocompatible and bioresorbable fibers, at least a portion of which may be crosslinked. The fibers include natural polymers or analogs or mixtures thereof. The matrix is adapted to have in vivo an outer surface contour substantially the same as that of a natural meniscus. The matrix has pore size in the approximate range of greater than 50 microns to less than about 500 microns. With this configuration, the matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of meniscal fibrochondrocytes.
Prosthetic Meniscus
US Patent:
5158574, Oct 27, 1992
Filed:
Nov 7, 1991
Appl. No.:
7/789011
Inventors:
Kevin R. Stone - San Francisco CA
Assignee:
ReGen Corporation - San Francisco CA
International Classification:
A61F 202, A61F 228, A61F 238
US Classification:
623 66
Abstract:
A prosthetic, resorbable meniscus and method of its fabrication are disclosed. The prosthetic meniscus can be implanted in a human knee where it can act as a scaffold for regrowth of native meniscal tissues. The meniscus comprises a dry, porous, matrix of biocompatible and bioresorbable fibers, at least a portion of which may be crosslinked. The fibers include natural polymers or analogs or mixtures thereof. The matrix is adapted to have in vivo an outer surface contour substantially the same as that of a natural meniscus. The matrix has pore size in the approximate range of greater than 50 microns to less than about 500 microns. With this configuration, the matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of meniscal fibrochondrocytes.